Systemic Sclerosis Market to Exhibit Significant Growth by 2034, Predicts DelveInsight | Key Companies - Kyowa Hakko Kirin, AstraZeneca, Mitsubishi Tanabe Pharma, Genentech, Amgen, GlaxoSm...
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
awareness, and the launch of potential therapies with novel mechanisms that are being investigated to improve the management of systemic sclerosis during the forecast period (2024–2034). LAS VEGAS June 27, 2024 /PRNewswire/ -- DelveInsight's Systemic Sclerosis Market Insights report includes a comprehensive understanding of current treatment practices, systemic sclerosis emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [ the United States , the EU4 ( Germany France Italy , and Spain ) and the United Kingdom , and Japan ]. Key Takeaways from the Systemic Sclerosis Market Report According to DelveInsight's analysis, the market size for systemic sclerosis is expected to grow significantly by 2034. Systemic sclerosis usually appears in women aged 30–40, and it occurs in slightly older men. In approximately of cases, systemic sclerosis develops in individuals aged 20–60 years. Leading systemic scler
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Advanced Liver Cancer Therapeutics Research 2024: Comprehensive Insights About 50+ Companies and 50+ Pipeline Drugs - Product Type, Stage, Route of Administration, and Molecule Type [Yahoo! Finance]Yahoo! Finance
- O'Shaughnessy Ventures Awards $100,000 Fellowship Grant to Biotech Entrepreneur Aiming to Revolutionize Microbiome Health Monitoring [Yahoo! Finance]Yahoo! Finance
- Tanium Wins Coveted Microsoft Independent Software Vendor Innovation Partner of the Year Award [Yahoo! Finance]Yahoo! Finance
- Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer [Yahoo! Finance]Yahoo! Finance
- AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 7/1/24 - Form 6-K
- 6/26/24 - Form 11-K
- 6/25/24 - Form 6-K
- AZN's page on the SEC website